Germline ERBB2/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms.
Braunstein EM, Chen H, Juarez F, Yang F, Tao L, Makhlin I, Williams DM, Chaturvedi S, Pallavajjala A, Karantanos T, Martin R, Wohler E, Sobreira N, Gocke CD, Moliterno AR.
Braunstein EM, et al. Among authors: moliterno ar.
Cancers (Basel). 2021 Jun 29;13(13):3246. doi: 10.3390/cancers13133246.
Cancers (Basel). 2021.
PMID: 34209587
Free PMC article.